Last reviewed · How we verify
HSK31858 Tablets and Itraconazole Capsules
HSK31858 Tablets and Itraconazole Capsules is a Small molecule drug developed by Haisco Pharmaceutical Group Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | HSK31858 Tablets and Itraconazole Capsules |
|---|---|
| Sponsor | Haisco Pharmaceutical Group Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HSK31858 Tablets and Itraconazole Capsules CI brief — competitive landscape report
- HSK31858 Tablets and Itraconazole Capsules updates RSS · CI watch RSS
- Haisco Pharmaceutical Group Co., Ltd. portfolio CI
Frequently asked questions about HSK31858 Tablets and Itraconazole Capsules
What is HSK31858 Tablets and Itraconazole Capsules?
HSK31858 Tablets and Itraconazole Capsules is a Small molecule drug developed by Haisco Pharmaceutical Group Co., Ltd..
Who makes HSK31858 Tablets and Itraconazole Capsules?
HSK31858 Tablets and Itraconazole Capsules is developed by Haisco Pharmaceutical Group Co., Ltd. (see full Haisco Pharmaceutical Group Co., Ltd. pipeline at /company/haisco-pharmaceutical-group-co-ltd).
What development phase is HSK31858 Tablets and Itraconazole Capsules in?
HSK31858 Tablets and Itraconazole Capsules is in Phase 1.